Welcome to our dedicated page for Nanobiotix S.A. SEC filings (Ticker: NNBXF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Nanobiotix S.A.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Nanobiotix S.A.'s regulatory disclosures and financial reporting.
Nanobiotix S.A. reports that trading in its ordinary shares on the regulated market of Euronext Paris has resumed as of 3:30 p.m. Paris time / 9:30 a.m. New York time on May 21, 2026.
Trading had been halted earlier that day at the company’s request in connection with a previously announced global securities offering. This global offering includes a U.S. public offering of American Depositary Shares, each representing one ordinary share with a nominal value of €0.03, and an international offering of ordinary shares and pre-funded warrants to qualified investors in Europe and certain other countries outside the United States and Canada.
Nanobiotix S.A. reports that trading of its ordinary shares on Euronext Paris is being temporarily halted at the company’s request. The halt is linked to a previously announced global equity financing that combines a U.S. public offering of American Depositary Shares with an international offering of ordinary shares and pre-funded warrants to qualified investors outside the United States and Canada.
The pause is intended to allow final allocation to investors and announcement of pricing for this global offering. Trading on Euronext Paris is expected to resume on May 21, 2026, at about 3:30 p.m. Paris time, which corresponds to 9:30 a.m. in New York.